Cationic lipid-based delivery system for systemic cancer gene therapy

Area of Science:

• Biotechnology
• Molecular Biology
• Cancer Research

Background:

• Systemic gene delivery for cancer therapy faces challenges in targeting and expression.
• Cationic lipid-based systems offer potential for plasmid delivery.
• Understanding tumor vascularity is crucial for effective gene delivery.

Purpose of the Study:

• To develop and characterize a cationic lipid-based gene delivery system for systemic administration.
• To evaluate plasmid biodistribution and transgene expression in a syngeneic mouse tumor model.
• To assess the therapeutic efficacy of interleukin-12 gene transfer in inhibiting tumor growth.

Main Methods:

• Development of a cationic lipid-DNA complex using N-[(1-(2,3-dioleyloxy)propyl)]-N-N-N-trimethylammonium chloride and cholesterol (4:1 molar ratio).
• Intravenous administration of reporter gene and interleukin-12 expression plasmids in squamous cell carcinoma VII tumor-bearing mice.
• Biodistribution analysis using fluorescence microscopy and protein level quantification.
• Tumor growth inhibition assessed via efficacy studies.

Main Results:

• The gene delivery system successfully transfected lungs and primary tumors.
• Fluorescently labeled complexes showed passive targeting to tumor vasculature, with endothelial cell internalization.
• Intravenous administration of interleukin-12 plasmid resulted in detectable protein levels.
• 15 microg of interleukin-12 plasmid significantly inhibited primary tumor growth.

Conclusions:

• The developed cationic lipid-based system enables effective systemic gene delivery and tumor transfection.
• The system demonstrates passive tumor targeting and successful transgene expression, leading to a biological response.
• This gene delivery approach shows promise for cancer therapy by inhibiting tumor growth through interleukin-12 expression.